A Model for Therapeutic Interventions on Established Coronary Atherosclerosis in a Nonhuman Primate

  • M. R. Malinow
  • Phyllis McLaughlin
  • Lynne Papworth
  • H. K. Naito
  • Lena Lewis
  • W. P. McNulty
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 67)


Modern medicine is faced with the challenge of helping hundreds of millions of individuals with undetected coronary atherosclerosis, many of whom will eventually develop ischemic heart disease and probably die as a consequence. To reduce the incidence of clinically unrecognized coronary atherosclerosis, a risk-free, noninvasive, and so far nonexistent method of detecting the progress of coronary atherosclerosis in man is long overdue. Until such a method becomes available, the most feasible alternative is to substitute an animal model in which coronary atherosclerosis can be induced and to study its progression, regression, or arrest. Nonhuman primates are a natural choice since spontaneous atherosclerotic lesions have been described in all species so far studied (1). But our knowledge of the incidence and prevalence of atherosclerosis in these models is limited because most reports are based on only a few animals (1). Furthermore, such spontaneous lesions are generally minimal (2,3) and do not impair normal arterial functions as they do in man. A priori, not every species of nonhuman primate appears to meet all the requirements for determining the effect of therapeutic interventions on the course of coronary atherosclerosis. However, monkeys had to be selected on the basis of availability, and the lesions induced were more advanced than the spontaneous type (1).


Plasma Cholesterol Nonhuman Primate Coronary Atherosclerosis Squirrel Monkey Cynomolgus Monkey 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    McNulty, W.P. and M.R. Malinow. 1972. The cardiovascular system. In: Pathology of Simian Primates. Ed. by R.N. T-W-Fiennes, Karger, Basel, pp. 756–808.Google Scholar
  2. 2.
    Malinow, M.R. and C.A. Maruffo. 1965. Naturally-occurring atherosclerosis in howler monkey (Alouatta caraya). J. Atheroscler. Res. 6:368–380.CrossRefGoogle Scholar
  3. 3.
    Malinow, M.R. and C.A. Storvick. 1968. Spontaneous coronary lesions in howler monkeys (Alouatta caraya). J. Atheroscler. Res. 8:421–431.PubMedCrossRefGoogle Scholar
  4. 4.
    Malinow, M.R., A. Perley and P.A. McLaughlin. 1968. The effects of pyridinolcarbamate on induced atherosclerosis in monkeys. J. Atheroscler. Res. 8:455–561.PubMedCrossRefGoogle Scholar
  5. 5.
    Clarkson, T.B., H.B. Lofland, Jr., B.C. Bullock and H.O. Goodman. 1971. Genetic control of plasma cholesterol: Studies on squirrel monkeys. Arch. Pathol. 92:37–45.PubMedGoogle Scholar
  6. 6.
    Lofland, H.B., Jr., T.B. Clarkson, R.W. St. Clair and N.D.M. Lehner. 1972. Studies on the regulation of plasma cholesterol levels in squirrel monkeys of two genotypes. J. Lipid Res. 13:39–47.PubMedGoogle Scholar
  7. 7.
    Taylor, C.B., P. Manalo-Estrella and G.E. Cox. 1963. Atherosclerosis in rhesus monkeys. Arch. Pathol. 76:239–249.PubMedGoogle Scholar
  8. 8.
    Pick, R., P.J. Johnson and G. Glick. 1974. Deleterious effects of hypertension on the development of aortic and coronary atherosclerosis in stumptail macaques (Macaca speciosa) on an atherogenic diet. Circ. Res. 35:472–482.PubMedCrossRefGoogle Scholar
  9. 9.
    Kramsch, D.M. and W. Hollander. 1968. Occlusive atherosclerotic disease of the coronary arteries in monkey (Macaca irus) induced by diet. Exp. Molec. Pathol. 9: 1–22.CrossRefGoogle Scholar
  10. 10.
    Taylor, C.G., G.E. Cox, P. Manalo-Estrella, J. Southworth, D.E. Patton and C. Cathcart. 1962. Atherosclerosis in rhesus monkeys. II. Arterial lesions associated with hypercholesterolemia induced by dietary fat and cholesterol. Arch. Pathol. 74:16–34.PubMedGoogle Scholar
  11. 11.
    Malinow, M.R. 1963. Hormones and atherosclerosis. Adv. Pharmacol. 2:211–242.CrossRefGoogle Scholar
  12. 12.
    Malinow, M.R. 1975. Rhesus monkey prices double. Nat. Soc. Med. Res. Bull. 26:(5):1.Google Scholar
  13. 13.
    Malinow, M.R. 1975. International Primate Protection League issues appeal for moratorium on purchase of stumptailed monkeys. Lab. Primate Newslett. 14(3):37.Google Scholar
  14. 14.
    Muckenhirn, N. 1975. Trends in primate imports into the United States. ILAR News 18(3):2.Google Scholar
  15. 15.
    Fillios, L.C. and G.V. Mann. 1956. The importance of sex in the variability of the cholesteremic response of rabbits fed cholesterol. Circ. Res. 4:406–412.PubMedCrossRefGoogle Scholar
  16. 16.
    Connor, W.E. and S.L. Connor. 1972. The key role of nutritional factors in the prevention of coronary disease. Prev. Med. 1:49–83.PubMedCrossRefGoogle Scholar
  17. 17.
    Imai, Y. and H. Matsumara. 1973. Genetic studies on induced and spontaneous hypercholesterolemia in rats. Atherosclerosis 18:59–64.PubMedCrossRefGoogle Scholar
  18. 18.
    Cox, G.E., C.B. Taylor, L.G. Cox and M.A. Counts. 1958. Atherosclerosis in rhesus monkeys. I. Hypercholesterolemia induced by dietary fat and cholesterol. Arch. Pathol. 66:32–52.Google Scholar
  19. 19.
    Rudel, L.L. and M.D. Morris. 1973. Determination of cholesterol using o-ophthalaldehyde. J. Lipid Res. 14:364–366.PubMedGoogle Scholar
  20. 20.
    Malinow, M.R., P. McLaughlin and A. Perley. 1972. The effect of pyridinolcarbamate on induced therosclerosis in cynomolgus monkeys. Atherosclerosis 15:31–36.PubMedCrossRefGoogle Scholar
  21. 21.
    Malinow, M.R., A.A. Pellegrino and E.H. Ramos. 1958. Chemical and anatomical correlations in cholesterol-fed rabbits. Acta Physiol. Latino Amer. 8:37–46.Google Scholar
  22. 22.
    Malinow, M.R. and A. Corcoran. 1966. Growth of the lens in howler monkeys (Alouatta caraya). J. Mammal. 47:58–63.PubMedCrossRefGoogle Scholar
  23. 23.
    Boyd, G.S. and M.F. Oliver. 1960. The effect of certain thyroxine analogues on the serum lipids in human subjects. J. Endocrinol. 21:33–43.CrossRefGoogle Scholar
  24. 24.
    Turner, K.B. 1933. Studies on the prevention of cholesterol atherosclerosis in rabbits. Effects of whole thyroid and of potassium iodide. J. Exper. Med. 58:115–125.CrossRefGoogle Scholar
  25. 25.
    Moyer, A.W., D. Kritchevsky, W.C. Tesar, J.B. Logan, R.F.J. McCandless, R.A. Brown and H.R. Cox. 1956. Effect of varying dosages of potassium iodide in experimental atherosclerosis. Proc. Soc. Exp. Biol. Med. 92:416–418.PubMedGoogle Scholar
  26. 26.
    Katz, L.N. and R. Pick. 1961. Experimental atherosclerosis as observed in the chicken. J. Atheroscler. Res. 1: 93–100.PubMedCrossRefGoogle Scholar
  27. 27.
    Selenkow, H.A. and S.P. Asper, Jr. 1955. Biological activity of compounds structurally related to thyroxine. Physiol. Rev. 15:426–474.Google Scholar
  28. 28.
    Fisher, E.R. 1964. Thyroidal influence on experimental cholesterol atherosclerosis. Am. J. Path. 45:21–39.PubMedGoogle Scholar
  29. 29.
    Kritchevsky, D., J.L. Moynihan, J. Langan, S.A. Tepper and M.L. Sachs. 1961. Effects of D-and L-thyroxine and of D-and L-3,5,3″-triiodo-thyronine on development and regression of experimental atherosclerosis in rabbits. J. Atheroscler. Res. 1: 211–221.PubMedCrossRefGoogle Scholar
  30. 30.
    Armstrong, M.L., E.D. Warner and W.E. Connor. 1970. Regression of coronary atheromatosis in rhesus monkeys. Circ. Res. 27:59–67.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1976

Authors and Affiliations

  • M. R. Malinow
    • 1
    • 2
    • 3
  • Phyllis McLaughlin
    • 1
    • 2
    • 3
  • Lynne Papworth
    • 1
    • 2
    • 3
  • H. K. Naito
    • 1
    • 2
    • 3
  • Lena Lewis
    • 1
    • 2
    • 3
  • W. P. McNulty
    • 1
    • 2
    • 3
  1. 1.Oregon Regional Primate Research CenterBeavertonUSA
  2. 2.University of Oregon Health Sciences CenterPortlandUSA
  3. 3.Cleveland ClinicClevelandUSA

Personalised recommendations